Advertisement
Research Article

BCA2/Rabring7 Promotes Tetherin-Dependent HIV-1 Restriction

  • Kei Miyakawa,

    Affiliations: AIDS Research Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan, Department of Molecular Virology, Graduate School of Medicine, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan

    X
  • Akihide Ryo mail,

    aryo@nih.go.jp (AR); nyama@nih.go.jp (NY)

    Affiliation: AIDS Research Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan

    X
  • Tsutomu Murakami,

    Affiliation: AIDS Research Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan

    X
  • Kenji Ohba,

    Affiliation: AIDS Research Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan

    X
  • Shoji Yamaoka,

    Affiliation: Department of Molecular Virology, Graduate School of Medicine, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan

    X
  • Mitsunori Fukuda,

    Affiliation: Department of Developmental Biology and Neurosciences, Graduate School of Life Sciences, Tohoku University, Sendai, Miyagi, Japan

    X
  • John Guatelli,

    Affiliation: Department of Medicine, University of California San Diego, La Jolla, California, United States of America

    X
  • Naoki Yamamoto mail

    aryo@nih.go.jp (AR); nyama@nih.go.jp (NY)

    Affiliation: AIDS Research Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan

    X
  • Published: December 18, 2009
  • DOI: 10.1371/journal.ppat.1000700

Reader Comments (0)

Post a new comment on this article